List your company

REPRESS

Drug discovery and biotech · by Deep Genomics

A deep learning foundation model that predicts cell-type-specific miRNA binding and mRNA degradation directly from RNA sequence; identifies repressive non-canonical miRNA target sites and decodes regulatory effects of sequence context and miRNA binding site multiplicity.

Visit website

What it does

A deep learning foundation model that predicts cell-type-specific miRNA binding and mRNA degradation directly from RNA sequence; identifies repressive non-canonical miRNA target sites and decodes regulatory effects of sequence context and miRNA binding site multiplicity.

  • AI-driven drug discovery
  • Molecular design
  • Target biology discovery
  • RNA therapeutic development
Category
Drug discovery and biotech
Users
Pharmaceutical companies, Drug discovery teams
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

Deep Genomics doesn't list prices publicly. Ask them for a quote.

Security and compliance

As reported by Deep Genomics. Ask for audit reports before you buy.

  • Administrative safeguards
  • Technical safeguards
  • Physical safeguards
  • Need-to-know access restriction
  • Record retention processes

Reviews

No reviews yet

Reviews come from people who use REPRESS at work. Share how your team uses it to help other buyers decide.

Write a review

Alternatives

  • mRNA 2.0 Platform

    by Kernal Biologics

    mRNA therapeutics platform that is intelligently programmed and selectively translated, using AI models to ensure selective translation in target cells and enabling scalable in...

  • 10x Science platform

    by 10x Science

    AI-native platform for next-generation protein characterization, peptide mapping, de novo sequencing, and proteoform analysis.

  • Foundry

    by Adaptyv Bio

    The cloud lab for protein designers and the protein engineering platform for drug discovery.

  • Duoseq Suite Report

    by Duoseq

    Output report generated after overnight sequencing, delivering structured, searchable molecular data that integrates directly with EPIC and other EHR systems.

  • Cell Counter

    by Bramante Biologics Corporation

    Cell counter instrument, API-ready out of the box.

  • Integrations

    by Invert

    Pre-built connectivity to every instrument, historian, ELN/LIMS, and enterprise data store that matters in bioprocess.

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim REPRESS